Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Disrupted latent inhibition in individuals at ultra high-risk for developing psychosis.

Kraus M, Rapisarda A, Lam M, Thong JYJ, Lee J, Subramaniam M, Collinson SL, Chong SA, Keefe RSE.

Schizophr Res Cogn. 2016 Aug 17;6:1-8. doi: 10.1016/j.scog.2016.07.003. eCollection 2016 Dec.

2.

Hazards in Motion: Development of Mobile Geofences for Use in Logging Safety.

Zimbelman EG, Keefe RF, Strand EK, Kolden CA, Wempe AM.

Sensors (Basel). 2017 Apr 10;17(4). pii: E822. doi: 10.3390/s17040822.

3.

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.

Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS.

Neuropsychopharmacology. 2016 Nov;41(12):2961. doi: 10.1038/npp.2016.181. No abstract available.

4.

Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.

Wang C, Ji F, Hong Z, Poh JS, Krishnan R, Lee J, Rekhi G, Keefe RS, Adcock RA, Wood SJ, Fornito A, Pasternak O, Chee MW, Zhou J.

Psychol Med. 2016 Oct;46(13):2771-83. doi: 10.1017/S0033291716001410. Epub 2016 Jul 11.

5.

Accuracy of WAAS-Enabled GPS-RF Warning Signals When Crossing a Terrestrial Geofence.

Grayson LM, Keefe RF, Tinkham WT, Eitel JU, Saralecos JD, Smith AM, Zimbelman EG.

Sensors (Basel). 2016 Jun 18;16(6). pii: E912. doi: 10.3390/s16060912.

6.

Validation of a Computerized test of Functional Capacity.

Keefe RSE, Davis VG, Atkins AS, Vaughan A, Patterson T, Narasimhan M, Harvey PD.

Schizophr Res. 2016 Aug;175(1-3):90-96. doi: 10.1016/j.schres.2016.03.038. Epub 2016 Apr 16.

7.

Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.

Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA.

Schizophr Res. 2016 Jan;170(1):156-61. doi: 10.1016/j.schres.2015.11.022. Epub 2015 Nov 30.

8.

Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

Atkins AS, Stroescu I, Spagnola NB, Davis VG, Patterson TD, Narasimhan M, Harvey PD, Keefe RS.

J Prev Alzheimers Dis. 2015 Jun;2(2):121-127.

9.

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.

Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, Frese FJ, Goff DC, Gold JM, Hooker CI, Kopelowicz A, Loebel A, McGurk SR, Opler LA, Pinkham AE, Stern RG.

Schizophr Bull. 2016 Jan;42(1):19-33. doi: 10.1093/schbul/sbv111. Epub 2015 Sep 11.

10.

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.

Keefe RS, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, Lombardo I, Hilt DC.

Neuropsychopharmacology. 2015 Dec;40(13):3053-60. doi: 10.1038/npp.2015.176. Epub 2015 Jun 19.

11.

Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, Liu F, Warfel D, Vyas G, Richardson CM, Fischer BA, Keller WR, Koola MM, Feldman SM, Russ JC, Keefe RS, Osing J, Hubzin L, August S, Walker TM, Buchanan RW.

J Clin Psychopharmacol. 2015 Aug;35(4):374-81. doi: 10.1097/JCP.0000000000000345.

12.

Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Iwata Y, Nakajima S, Suzuki T, Keefe RS, Plitman E, Chung JK, Caravaggio F, Mimura M, Graff-Guerrero A, Uchida H.

Mol Psychiatry. 2015 Oct;20(10):1151-60. doi: 10.1038/mp.2015.68. Epub 2015 Jun 16. Review.

13.

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.

Walling D, Marder SR, Kane J, Fleischhacker WW, Keefe RS, Hosford DA, Dvergsten C, Segreti AC, Beaver JS, Toler SM, Jett JE, Dunbar GC.

Schizophr Bull. 2016 Mar;42(2):335-43. doi: 10.1093/schbul/sbv072. Epub 2015 Jun 12.

14.

Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia).

Araújo GE, Resende CB, Cardoso AC, Teixeira AL, Keefe RS, Salgado JV.

Clinics (Sao Paulo). 2015 Apr;70(4):278-82. doi: 10.6061/clinics/2015(04)10.

15.

Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.

Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA.

Schizophr Res. 2015 Aug;166(1-3):310-5. doi: 10.1016/j.schres.2015.05.018. Epub 2015 May 23.

16.

Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH.

Psychol Med. 2015;45(12):2657-66. doi: 10.1017/S0033291715000641. Epub 2015 Apr 28. Erratum in: Psychol Med. 2016 Apr;46(5):1119.

17.

Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.

Klauser P, Zhou J, Lim JK, Poh JS, Zheng H, Tng HY, Krishnan R, Lee J, Keefe RS, Adcock RA, Wood SJ, Fornito A, Chee MW.

Schizophr Bull. 2015 Nov;41(6):1285-93. doi: 10.1093/schbul/sbv012. Epub 2015 Mar 4.

18.

A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.

Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS.

Neuropsychopharmacology. 2015 Jul;40(8):2025-37. doi: 10.1038/npp.2015.52. Epub 2015 Feb 17.

19.

Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study.

Bauer IE, Ouyang A, Mwangi B, Sanches M, Zunta-Soares GB, Keefe RS, Huang H, Soares JC.

J Psychiatr Res. 2015 Mar;62:115-22. doi: 10.1016/j.jpsychires.2015.01.008. Epub 2015 Feb 7.

20.

Observable Social Cognition--A Rating Scale: an interview-based assessment for schizophrenia.

Healey KM, Combs DR, Gibson CM, Keefe RS, Roberts DL, Penn DL.

Cogn Neuropsychiatry. 2015;20(3):198-221. doi: 10.1080/13546805.2014.999915. Epub 2015 Feb 13.

Supplemental Content

Loading ...
Support Center